این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Journal of Pharmaceutical Care، جلد ۱۰، شماره ۱، صفحات ۲۲-۲۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Effects of Pulse Dose of Corticosteroids in Hospitalized Patients with COVID-19: An Observational Study
چکیده انگلیسی مقاله Background: Although corticosteroids are commonly used for COVID-19 disease during the inflammatory phase, the effective doses and the best choice of corticosteroids are not yet known. Methods: In the present study, the effects of non-pulse (30-250 mg/day of prednisolone equivalent) versus pulse equivalent (>250 mg/day of prednisolone equivalent) doses of corticosteroids are compared in terms of the patients’ oxygen saturation, hospital mortality, and side effects. In addition, the patients were followed for 2 months for readmission and mortality. Results: 270 severe or critically ill patients with COVID-19 disease were included in the study. Diabetes and hypertension were the most common comorbidities. More than 80% of the patients received corticosteroids. Pulse equivalent doses of corticosteroids were used in 36.9 % of the patients. Treatment with pulse doses of corticosteroid significantly increased the oxygen saturation in the critically ill patients. However, the pulse doses significantly increased the in-hospital mortality rate [29 (20.3%) vs. 12 (10.6%), p=0.036] and the side effects. In addition, a trend toward higher 60-day mortality was observed in the pulse-based-treated patients [31 (21.7%) vs. 14 (12.4%), p=0.053]. The multivariate analysis showed that having comorbidities increased the mortality risk independently [OR 3.33, CI 1.148-9.647]. Conclusion: The results showed that the pulse doses of corticosteroids increase the oxygen saturation, but they also can increase mortality. Further randomized controlled trials with larger sample sizes are needed to confirm our findings.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Hadis Nikpour
Department of Clinical Pharmacy, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.


| Fatemeh Heydarpour
Social Development & Health Promotion Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.


| Mohammad Hossein Zamanian
Department of Infectious Disease, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.


| Siavash Vaziri
Department of Infectious Disease, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.


| Foroud Shahbazi
Department of Clinical Pharmacy, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
نشانی اینترنتی https://jpc.tums.ac.ir/index.php/jpc/article/view/461
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات